By using mass spectrometry-based quantitative proteomics analysis, we discovered that strophanthidin (SPTD) upregulated 24 proteins, including Banf1 and LAMN, and downregulated 35 proteins, such as SRSF3 and COL1A5, in A549 cancer cells. The gene discussed is SRSF3; the disease is cancer.